Yazan Abou-Ismail Have Been Selected for the Legacy Award at the 30th Anniversary of the Qatar Foundation
Yazan Abou-Ismail, Associate Professor of Hematology at University of Utah, shared a post on LinkedIn:
“What a true honor it is to be recognized by Her Excellency Sheikha Hind bint Hamad Al-Thani, at the 30th anniversary of the Qatar Foundation, and by Her Highness Sheikha Moza bint Nasser previously in Doha. I am truly humbled to have been selected from among 278 nominations for the Legacy Award among such distinguished guests and alumni.
The real legacy is QF’s remarkable journey of transforming education, driving innovation, and investing in human potential. The QF alumni carry remarkable stories of success worldwide, and I’m grateful to be a small part of this extraordinary legacy. Thank you again to the QF and its leadership for this honor and for such a wonderful night. So great to reconnect with QF Alumni Program and Weill Cornell Medicine – Qatar WCMQ Alumni Affairs Office.”
Discover the latest in Hemostasis Today.
-
Dec 17, 2025, 15:24Laura Dormer on a Motor Relearning Program for Chronic Stroke Patients
-
Dec 17, 2025, 15:01WSO: United Nations Has Formally Adopted the Political Declaration on NCDs and Mental Health
-
Dec 17, 2025, 14:44Bryan Unger: 1st Patient Has Been Enrolled in NuvOx Therapeutics’ Phase IIb NOVEL Trial
-
Dec 17, 2025, 14:29Sarah Richardson: Feeling So Proud to Be a Part of the Advocacy Team for the HFA
-
Dec 17, 2025, 06:28Wolfgang Miesbach on Linus Völker’s Presentation of Caplacizumab as Frontline Therapy for iTTP
-
Dec 17, 2025, 06:11Lisa Murphy Thanks Stroke Foundation Team for An Impactful, Rewarding and Incredible Year
-
Dec 17, 2025, 06:05Emmanuel J Favaloro Shares A Study on AI and Machine Learning in Thrombosis and Hemostasis
-
Dec 17, 2025, 05:54Michael Bruckman: Fantastic to See Platelet-Inspired Nanoparticles Gaining Attention!
-
Dec 17, 2025, 04:00Peter Verhamme on Genetic Predisposition to Thromboembolism and COVID